Skip to main content
. Author manuscript; available in PMC: 2023 Dec 21.
Published in final edited form as: J Hepatol. 2023 May 8;79(3):853–866. doi: 10.1016/j.jhep.2023.04.033

Fig. 3. An algorithm to approach suspected DI-ALH in clinical practice.

Fig. 3.

*Alternatively, in mild cases associated with specific drugs known to induce this phenotype (i.e. infliximab), which show clinical/biochemical improvement following drug withdrawal, a liver biopsy is not always necessary. DI-ALH, drug-induced autoimmune-like hepatitis.